Last, we identified and demonstrated by RNA-seq that PRR11 activates the AKT signaling pathway by down-regulating PTEN in RCC, but the specific molecular biological mechanisms still need to be further elucidated in future. Here, AKT1 is linked to renal cell carcinoma.